Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

This study has been completed.

Sponsor:

Information provided by:

North Shore Long Island Jewish Health System

ClinicalTrials.gov Identifier:

NCT00621075

First received: January 17, 2008

Last updated: March 8, 2010

Last verified: March 2010

History of Changes

Tracking Information

First Received Date ^ICMJE

January 17, 2008

Last Updated Date

March 8, 2010

Start Date ^ICMJE

April 2007

Primary Completion Date

February 2008 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00621075 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

Official Title ^ICMJE

Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

Brief Summary

The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.

Detailed Description

Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

Pulmonary Arterial Hypertension

Condition ^ICMJE

Pulmonary Arterial Hypertension

Intervention ^ICMJE

Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans

Correlation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements

Other Name: Pulmonary Arterial Hypertension

Study Group/Cohort (s)

Pulmonary Arterial Hypertension

Intervention: Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

February 2008

Primary Completion Date

February 2008 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Pulmonary Arterial Hypertension

Exclusion Criteria:

Non-Pulmonary Arterial Hypertension

Gender

Both

Ages

18 Years to 80 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00621075

Other Study ID Numbers ^ICMJE

07.014, NORTH SHORE IRB

Has Data Monitoring Committee

Responsible Party

ARUNABH TALWAR MD, NORTH SHORE-LONG ISLAND JEWIAH HEALTH SYSTEM

Study Sponsor ^ICMJE

North Shore Long Island Jewish Health System

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

ARUNABH TALWAR, MD

NORTH SHORE-LIJ HEALTH SYSTEM

Information Provided By

North Shore Long Island Jewish Health System

Verification Date

March 2010

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top